// App-Quantinova.ai

O35 : Efficacy & safety of tocilizumab in GCA: a multi-centre experience of NHS clinical practice

Researchers

Presenter

  • Alwin Sebastian

Principal Investigators

  • Abdul Kayani

  • Chavini Ranasinghe

  • Frances Hall

  • Colin Ransom

  • David Jayne

  • Vanessa Quick

  • Mark Hughes

  • John Stack

  • Chetan Mukhtyar

  • Fiona Coath

  • Anurag Bharadwaj

  • Vijay Hajela

  • Stephanie Butler

  • May Lwin

  • Christopher Edwards

  • Madeline Whitlock

  • Bhaskar Dasgupta

Medical Centers

  • Rheumatology, Southend University Hospital NHS Trust, Southend-on-Sea, United Kingdom

  • Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge

  • Medicine, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UNITED KINGDOM

  • Rheumatology, Luton & Dunstable Hospital NHS Trust, Luton, UNITED KINGDOM

  • Rheumatology, Bolton Hospitals NHS Foundation Trust, Bolton, UNITED KINGDOM

  • Rheumatology, Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UNITED KINGDOM

  • Rheumatology, Basildon and Thurrock University Hospital Foundation Trust, Baslidon, UNITED KINGDOM

  • Rheumatology, Brighton and Sussex University Hospitals NHS Trust, Brighton, UNITED KINGDOM

  • Rheumatology, University Hospital Southampton NHS Foundation Trust, Southampton, UNITED KINGDOM

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Tocilizumab

Outcome

  • N/A

Study Design

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved